Dr. Fortin and her team thank the following grant agencies and programs for supporting their most recent research programs.

NIA NIH 1K08AG071985-01A1

May 2022- April 2027
Title: Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model
Role: Principal Investigator 

ASIP Summer Research Program
Summer 2022

NIA NIH 1 R21 AG070447-01A1 
September 2021-August 2023  
Title:  Small molecule inhibitors of hyperphosphorylated tau aggregation and cytotoxicity for the development of Alzheimer’s therapeutics 
Role: Principal Investigator 

PhRMA Research Starter Grant – Drug Discovery
September 2021-September 2022
Title: Characterization of new inhibitors of p-tau aggregation and cytotoxicity
Role: Principal Investigator

ASIP Summer Research Program
Summer 2020 

Winn Feline Foundation
August 2020-August 2022
Title: In Vitro Characterization of Small Molecule Inhibitors of Pancreatic Amyloidosis for Diabetic Cats.
Role: Principal Investigator

ACVIM Resident Research Grant Proposal, Pituitary Pars Intermedia Dysfunction project in horse
June 2019-January 2021
Title: Pituitary Pars Intermedia Dysfunction (PPID): Is abnormal protein accumulation associated with degeneration of hypothalamic dopaminergic neurons?
Role: Co-mentor
Principal Investigator: Harold Schott


Learn more about how you can donate to support our lab's work.